Research Site

Naperville, Illinois 60566-7226

1 studies enrolling now · 11 studies all time

What they study most

Affective Psychosis, Bipolar, Breast Cancer, Breast Cancer, Early Breast Cancer, Carcinoma, Carcinoma, Non-Small-Cell Lung, Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD), Major Depressive Disorder, Mania, Manic Disorder, Manic State, Manic-Depressive Psychosis, Metastases

Studies at this site

• A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05) — Recruiting now
• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
• A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC — Recruiting now
• Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation — Running, not enrolling
• Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma — Completed
• Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim — Completed
• Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia — Completed
• Iressa Expanded Access Program (EAP) — Completed
• Phase 3 /Seroquel SR Acute Mania Monotherapy - US — Completed
• Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders — Completed
• Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders — Completed